Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis

di Uitdehaag, Bernard M. J.
Pubblicato in CNS Drugs (2018)

Outcome Measures in Clinical Trials for Multiple Sclerosis

di van Munster, Caspar E. P., Uitdehaag, Bernard M. J.
Pubblicato in CNS Drugs (2017)

Regression-Based Norms for the Symbol Digit Modalities Test in the Dutch Population: Improving Detection of Cognitive Impairment in Multiple Sclerosis?

di Burggraaff, Jessica, Knol, Dirk L., Uitdehaag, Bernard M.J.
Pubblicato in Eur Neurol (2017)

Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.

di Schrijver, Hans M, van As, Jaco, Crusius, J Bart A, Dijkstra, Christien D, Uitdehaag, Bernard M J
Pubblicazione 2003

Structure‐function relationships in the visual system in multiple sclerosis: an MEG and OCT study

di Tewarie, Prejaas, Balk, Lisanne J., Hillebrand, Arjan, Steenwijk, Martijn D., Uitdehaag, Bernard M. J., Stam, Cornelis J., Petzold, Axel
Pubblicato in Ann Clin Transl Neurol (2017)

Evaluation of the content coverage of questionnaires containing basic and instrumental activities of daily living (ADL) used in adult patients with brain tumors

di Oort, Quirien, Taphoorn, Martin J. B., Sikkes, Sietske A. M., Uitdehaag, Bernard M. J., Reijneveld, Jaap C., Dirven, Linda
Pubblicato in J Neurooncol (2019)

N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry

di Jasperse, Bas, Jakobs, Cornelis, Eikelenboom, M. Judith, Dijkstra, Christine D., Uitdehaag, Bernard M. J., Barkhof, Frederik, Polman, Chris H., Teunissen, Charlotte E.
Pubblicazione 2007

Pediatric meningiomas in The Netherlands 1974–2010: a descriptive epidemiological case study

di Thuijs, Nikki B., Uitdehaag, Bernard M. J., Van Ouwerkerk, Willem J. R., van der Valk, Paul, Vandertop, W. Peter, Peerdeman, Saskia M.
Pubblicazione 2012

Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set

di Koch, Marcus W., Cutter, Gary R., Giovannoni, Gavin, Uitdehaag, Bernard M.J., Wolinsky, Jerry S., Davis, Mat D., Steinerman, Joshua R., Knappertz, Volker
Pubblicato in Neurol Neuroimmunol Neuroinflamm (2017)

Explaining the heterogeneity of functional connectivity findings in multiple sclerosis: An empirically informed modeling study

di Tewarie, Prejaas, Steenwijk, Martijn D., Brookes, Matthew J., Uitdehaag, Bernard M. J., Geurts, Jeroen J. G., Stam, Cornelis J., Schoonheim, Menno M.
Pubblicato in Hum Brain Mapp (2018)

Longitudinal Development of Peripapillary Hyper‐Reflective Ovoid Masslike Structures Suggests a Novel Pathological Pathway in Multiple Sclerosis

di Petzold, Axel, Coric, Danko, Balk, Lisanne J., Hamann, Steffen, Uitdehaag, Bernard M. J., Denniston, Alastair K., Keane, Pearse A., Crabb, David P.
Pubblicato in Ann Neurol (2020)

A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis

di Bazelier, Marloes T., van Staa, Tjeerd-Pieter, Uitdehaag, Bernard M.J., Cooper, Cyrus, Leufkens, Hubert G.M., Vestergaard, Peter, Bentzen, Joan, de Vries, Frank
Pubblicazione 2012

SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort

di van Kempen, Zoé L. E., Strijbis, Eva M. M., Al, Marissa M. C. T., Steenhuis, Maurice, Uitdehaag, Bernard M. J., Rispens, Theo, Killestein, Joep
Pubblicato in JAMA Neurol (2021)

Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With...

di Wijburg, Martijn T., Kleerekooper, Iris, Lissenberg-Witte, Birgit I., de Vos, Marlieke, Warnke, Clemens, Uitdehaag, Bernard M. J., Barkhof, Frederik, Killestein, Joep, Wattjes, Mike P.
Pubblicato in JAMA Neurol (2018)

Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15

di Kappos, Ludwig, Kuhle, Jens, Multanen, Juha, Kremenchutzky, Marcelo, Verdun di Cantogno, Elisabetta, Cornelisse, Peter, Lehr, Lorenz, Casset-Semanaz, Florence, Issard, Delphine, Uitdehaag, Bernard M J
Pubblicato in J Neurol Neurosurg Psychiatry (2015)

Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis

di Naegelin, Yvonne, Naegelin, Peter, von Felten, Stefanie, Lorscheider, Johannes, Sonder, Judith, Uitdehaag, Bernard M. J., Scotti, Barbara, Zecca, Chiara, Gobbi, Claudio, Kappos, Ludwig, Derfuss, Tobias
Pubblicato in JAMA Neurol (2019)

Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method

di Popescu, Veronica, Schoonheim, Menno M., Versteeg, Adriaan, Chaturvedi, Nimisha, Jonker, Marianne, Xavier de Menezes, Renee, Gallindo Garre, Francisca, Uitdehaag, Bernard M. J., Barkhof, Frederik, Vrenken, Hugo
Pubblicato in PLoS One (2016)

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

di Balk, Lisanne J., Cruz-Herranz, Andrés, Albrecht, Philipp, Arnow, Sam, Gelfand, Jeffrey M., Tewarie, Prejaas, Killestein, Joep, Uitdehaag, Bernard M. J., Petzold, Axel, Green, Ari J.
Pubblicato in J Neurol (2016)

A model for interrogating the clinico‐radiological paradox in multiple sclerosis: Internuclear ophthalmoplegia

di Nij Bijvank, Jenny A., Sánchez Aliaga, Esther, Balk, Lisanne J., Coric, Danko, Davagnanam, Indran, Tan, H. Stevie, Uitdehaag, Bernard M. J., van Rijn, Laurentius J., Petzold, Axel
Pubblicato in Eur J Neurol (2021)

Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial

di Nauta, Ilse M., Speckens, Anne E. M., Kessels, Roy P. C., Geurts, Jeroen J. G., de Groot, Vincent, Uitdehaag, Bernard M. J., Fasotti, Luciano, de Jong, Brigit A.
Pubblicato in BMC Neurol (2017)